Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700013084

Trial Profile

Clinical Trials Insight: 700013084

Phase of Trial: Phase I

Latest Information Update: 13 Mar 2008

At a glance

  • Drugs ENMD 1198 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Sponsors CASI Pharmaceuticals
  • Most Recent Events

    • 25 Oct 2007 Interim results were presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer.
    • 23 May 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top